Allergic Conjunctivitis MarketSize and Trends

The Global Allergic Conjunctivitis Market is estimated to be valued at US$ 2,486.7 million in 2021 and is expected to exhibit a CAGR of 5.4% during the forecast period (2021-2028).

Figure 1.Global Allergic Conjunctivitis Market Share (%) in Terms of Value, By Drug Class, 2021

Increasing prevalence and incidence of allergic conjunctivitis expected to drive the market growth during the forecast period.

The increase in incidence and prevalence of allergic conjunctivitis is expected to drive the global allergic conjunctivitis market growth over the forecast period. For instance, according to Clinical Epidemiology and Global Health, in India, the prevalence of allergic conjunctivitis was 12.22% where allergic conjunctivitis was reported in more males (13.44%) as compared to females (10.71%) in 2019.

Key companies focusing on research and development of allergic conjunctivitis are expected to drive the market growth during the forecast period.

Key players operating in the market are focusing on development of treatments for allergic conjunctivitis, this is expected to drive the global allergic conjunctivitis market growth during the forecast period. For instance, in April 2020, Ocular Therapeutix, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, announced topline results from its Phase 3 clinical trial to evaluate the safety and efficacy of DEXTENZA for the treatment of ocular itching associated with allergic conjunctivitis (AC).

Figure 2.Global Allergic Conjunctivitis Market Share (%), By Disease Type, 2021